It is a pharma public limited company based in Muzaarnagar, Uttar Pradesh, India, established in 2005.
2005 | Muzaarnagar, Uttar Pradesh, India | ActiveGemini Pharmaceuticals Limited, a active public limited company, was established on 02 August 2005 in Muzaarnagar, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232UP2005PLC030446. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.25 Cr and a paid-up capital of ₹2.20 Cr.
It upholds a active non-compliant status. Its leadership includes Ramdev (Additional Director), Kuwar Singh (Additional Director), Sudhir Kumar (Director). Past directors included Venkat Reddy Kudimuskula, Bharti Garg, Anita Garg. It holds ₹5.27 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19-A, New Mandi, Muzaarnagar, Uttar Pradesh, 251001.
U24232UP2005PLC030446
030446
02 August 2005
₹2.25 Cr
₹2.20 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Gemini Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramdev | Additional Director | 25 Mar 2023 | Current |
| Kuwar Singh | Additional Director | 15 Apr 2016 | Current |
| Sudhir Kumar | Director | 01 Oct 2016 | Current |
| Ajay Kumar Sharma | Additional Director | 21 Feb 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 04 Dec 2016 | Past |
| Pramod Abcsdd | Additional Director | 04 Dec 2016 | Past |
| Pramod Abcsdd | Director | 30 Mar 2011 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gemini Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.43% decrease. The company also saw a substantial improvement in profitability, with a 73.92% increase in profit. The company's net worth moved up by a moderate rise of 4.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Gemini Pharmaceuticals had a promoter holding of 25.64% and a public holding of 74.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹52,688,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2006 | State Bank Of India | ₹5.27 Cr | Open |
Explore comprehensive loan charge details -
Gemini Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gemini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gemini Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gemini Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Gemini Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity Ramdev was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
Progress on Sudhir Kumar was appointed as a Director was appointed as a Director on 01 Oct 2016 & has been associated with this company since 9 years 2 months . was documented.
The activity Kuwar Singh was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
Progress on Ajay Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 21 Feb 2012 & has been associated with this company since 13 years 9 months . was documented.
The CIN of Gemini Pharmaceuticals Limited is U24232UP2005PLC030446.
Gemini Pharmaceuticals Limited is headquartered at 19-A, New Mandi, Muzaarnagar, Uttar Pradesh, 251001.
Gemini Pharmaceuticals Limited was incorporated on 02 August 2005.
The current directors of Gemini Pharmaceuticals Limited are
The primary industry of Gemini Pharmaceuticals Limited is Pharma.
Gemini Pharmaceuticals Limited is unlisted.
The authorized capital of Gemini Pharmaceuticals Limited is ₹2.25 Cr, and the paid-up capital is ₹2.20 Cr.
The compliance status of Gemini Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX